Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Health

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

The Guardian

HealthThe Guardian·Jun 3, 2026·1 min read

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its…

View original source — The Guardian ↗

ShareShare on X Share on Facebook

Related stories

NHS approves first new ovarian cancer treatment for 20 years

HealthJun 4, 2026 · 1 min

NHS approves first new ovarian cancer treatment for 20 years

New NHS drug offers ovarian cancer patients more time and better quality of life

HealthJun 3, 2026 · 1 min

New NHS drug offers ovarian cancer patients more time and better quality of life

‘Impossible dream’ now a reality for history-making Kiwi cancer patient

HealthJun 8, 2026 · 1 min

‘Impossible dream’ now a reality for history-making Kiwi cancer patient

UniQure Shares Soar After FDA Reversal on Its Huntington’s Therapy

ScienceJun 17, 2026 · 1 min

UniQure Shares Soar After FDA Reversal on Its Huntington’s Therapy